Analysts’ Updated EPS Estimates for April 15th (ADEA, AMRC, APTV, ATGE, BME, CABP, CANF, CVX, CYTK, ELV)

Analysts’ updated eps estimates for Tuesday, April 15th:

Adeia (NASDAQ:ADEA) had its buy rating reissued by analysts at BWS Financial. They currently have a $18.00 price target on the stock.

Ameresco (NYSE:AMRC) had its neutral rating reaffirmed by analysts at Robert W. Baird. The firm currently has a $13.00 target price on the stock, down from their previous target price of $25.00.

Aptiv (NYSE:APTV) had its equal weight rating reissued by analysts at Barclays PLC. They currently have a $55.00 target price on the stock, down from their previous target price of $80.00.

Adtalem Global Education (NYSE:ATGE) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $120.00 price target on the stock.

B&M European Value Retail (LON:BME) had its not rated rating reaffirmed by analysts at Shore Capital.

CAB Payments (LON:CABP) had its house stock rating reissued by analysts at Shore Capital.

Can-Fite BioPharma (NYSE:CANF) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $10.00 target price on the stock.

Chevron (NYSE:CVX) had its neutral rating reaffirmed by analysts at BNP Paribas. The firm currently has a $140.00 target price on the stock.

Cytokinetics (NASDAQ:CYTK) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $120.00 target price on the stock.

Elevance Health (NYSE:ELV) had its neutral rating reiterated by analysts at Robert W. Baird. They currently have a $529.00 price target on the stock, down from their previous price target of $625.00.

Everyman Media Group (LON:EMAN) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 160 ($2.11) target price on the stock.

Exelon (NASDAQ:EXC) had its in-line rating reaffirmed by analysts at Evercore ISI. Evercore ISI currently has a $48.00 target price on the stock, up from their previous target price of $46.00.

Greatland Gold (LON:GGP) had its speculative buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 20 ($0.26) price target on the stock.

GoldMining (NYSEAMERICAN:GLDG) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $3.25 target price on the stock.

General Motors (NYSE:GM) (TSE:GMM.U) had its equal weight rating reissued by analysts at Barclays PLC. The firm currently has a $40.00 price target on the stock, down from their previous price target of $70.00.

Gentex (NASDAQ:GNTX) had its neutral rating reiterated by analysts at Robert W. Baird. Robert W. Baird currently has a $25.00 price target on the stock, down from their previous price target of $31.00.

HCA Healthcare (NYSE:HCA) had its neutral rating reissued by analysts at Robert W. Baird. Robert W. Baird currently has a $336.00 target price on the stock, down from their previous target price of $396.00.

Helical (LON:HLCL) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 280 ($3.69) price target on the stock.

Hoth Therapeutics (NASDAQ:HOTH) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $5.00 price target on the stock.

Howmet Aerospace (NYSE:HWM) had its equal weight rating reiterated by analysts at Wells Fargo & Company. The firm currently has a $118.00 price target on the stock, down from their previous price target of $132.00.

Hexcel (NYSE:HXL) had its equal weight rating reiterated by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $55.00 target price on the stock, down from their previous target price of $63.00.

ImmunityBio (NASDAQ:IBRX) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $30.00 price target on the stock.

IntegraFin (LON:IHP) had its buy rating reissued by analysts at Shore Capital.

3i Group (LON:III) had its buy rating reiterated by analysts at Citigroup Inc.. They currently have a GBX 4,850 ($63.95) target price on the stock.

Immunic (NASDAQ:IMUX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $10.00 price target on the stock.

Ionis Pharmaceuticals (NASDAQ:IONS) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $60.00 target price on the stock.

Interpublic Group of Companies (NYSE:IPG) had its buy rating reiterated by analysts at Citigroup Inc.. They currently have a $35.00 target price on the stock.

Ironwood Pharmaceuticals (NASDAQ:IRWD) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $0.70 target price on the stock, down from their previous target price of $8.00.

Ironwood Pharmaceuticals (NASDAQ:IRWD) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. The firm currently has a $1.00 price target on the stock, down from their previous price target of $7.00.

Kooth (LON:KOO) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 300 ($3.96) target price on the stock.

Littelfuse (NASDAQ:LFUS) had its neutral rating reiterated by analysts at Robert W. Baird. They currently have a $182.00 price target on the stock, down from their previous price target of $225.00.

Grand Canyon Education (NASDAQ:LOPE) had its outperform rating reissued by analysts at Barrington Research. They currently have a $205.00 target price on the stock.

Lowe’s Companies (NYSE:LOW) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $305.00 target price on the stock.

Mobileye Global (NASDAQ:MBLY) had its equal weight rating reiterated by analysts at Barclays PLC. The firm currently has a $14.00 target price on the stock, down from their previous target price of $22.00.

Magnite (NASDAQ:MGNI) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $14.00 price target on the stock.

Molina Healthcare (NYSE:MOH) had its neutral rating reissued by analysts at Robert W. Baird. They currently have a $375.00 price target on the stock, up from their previous price target of $331.00.

NIOX Group (LON:NIOX) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 90 ($1.19) target price on the stock.

NIOX Group (LON:NIOX) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 90 ($1.19) price target on the stock.

Omnicom Group (NYSE:OMC) had its buy rating reiterated by analysts at Citigroup Inc.. The firm currently has a $103.00 target price on the stock.

PepsiCo (NASDAQ:PEP) had its neutral rating reaffirmed by analysts at Bank of America Co.. They currently have a $155.00 price target on the stock, down from their previous price target of $185.00.

Paramount Group (NYSE:PGRE) had its underweight rating reiterated by analysts at Morgan Stanley. They currently have a $3.25 target price on the stock.

PPG Industries (NYSE:PPG) had its neutral rating reiterated by analysts at Bank of America Co.. Bank of America Co. currently has a $126.00 target price on the stock, down from their previous target price of $143.00.

Porvair (LON:PRV) had its hold rating reissued by analysts at Shore Capital.

Rallybio (NASDAQ:RLYB) had its hold rating reaffirmed by analysts at Jones Trading.

Renold (LON:RNO) had its buy rating reissued by analysts at Shore Capital.

Soleno Therapeutics (NASDAQ:SLNO) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $100.00 target price on the stock.

Strategic Education (NASDAQ:STRA) had its outperform rating reissued by analysts at Barrington Research. They currently have a $120.00 price target on the stock.

tinyBuild (LON:TBLD) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 10 ($0.13) target price on the stock.

tinyBuild (LON:TBLD) had its hold rating reaffirmed by analysts at Shore Capital.

Tenet Healthcare (NYSE:THC) had its neutral rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $137.00 price target on the stock, down from their previous price target of $153.00.

Interface (NASDAQ:TILE) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $30.00 price target on the stock.

TOMI Environmental Solutions (NASDAQ:TOMZ) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $3.50 target price on the stock.

Universal Health Services (NYSE:UHS) had its neutral rating reiterated by analysts at Robert W. Baird. Robert W. Baird currently has a $224.00 price target on the stock, down from their previous price target of $274.00.

Ur-Energy (NYSEAMERICAN:URG) (TSE:URE) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $2.70 price target on the stock.

Valneva (NASDAQ:VALN) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $17.00 target price on the stock.

Visteon (NASDAQ:VC) had its equal weight rating reaffirmed by analysts at Barclays PLC. The firm currently has a $82.00 price target on the stock, down from their previous price target of $110.00.

Zscaler (NASDAQ:ZS) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $235.00 target price on the stock.